Delivery Order SPE2DB22D3011-SPE2DB25FQ2AZ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed price delivery order, valued at $58,369.02, represents a non-competitive, non-set-aside award and is scheduled for completion by August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Venclexta 100 mg tablets in quantities of 120 units. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by August 13, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units) under a firm fixed-price arrangement. The contract, valued at $9,728.17, is scheduled for completion by August 11, 2025, and was awarded on July 21, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order represents a competitively awarded, non-set-aside contract...
- The Defense Logistics Agency awarded a $4,579.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for VENCLEXTA 100 mg tablets (28-count units) on July 30, 2025, with an ultimate completion date of August 20, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of VENCLEXTA 100 mg tablets (120 count), valued at $9,728.17. This firm fixed-price, competitively awarded delivery order is expected to be completed by August 14, 2025, with performance to be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a ceiling value of $9,728.17. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on July 21, 2025, with an ultimate completion date of August 11, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through an open process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $9,728.17 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg, a pharmaceutical product used in cancer treatment. This competitively awarded, non-set-aside contract is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order operates under a firm fixed-price structure and is classified as a child contract, meaning it...
- This delivery order awards $11,826.42 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units), with an ultimate completion date of August 14, 2025. The contract was competitively awarded without set-aside provisions and employs firm fixed-price terms. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing this order from its corporate office location in the same city. The Defense Logistics Agency, operating under the Department of...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2AZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Venclexta 100 mg tablets (quantity: 120 units) under a firm fixed-price contract valued at $9,728.17. This is a non-set-aside competitive award with an ultimate completion date of August 20, 2025, and performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contract awards with DLA demonstrate consistent capability in fulfilling competitive pharmaceutical supply requirements across multiple therapeutic domains, supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Venclexta is a specialized oncology medication, and this award reflects AmerisourceBergen's role in ensuring the availability of critical pharmaceutical products for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 7/30/25 |